Dafna Capital Management LLC Cytokinetics Inc Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

A detailed history of Dafna Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Dafna Capital Management LLC holds 398,100 shares of CYTK stock, worth $18.2 Million. This represents 5.4% of its overall portfolio holdings.

Number of Shares

398,100

Previous 398,100 -0.0%

Holding current value

$18.2 Million

Previous $21.6 Million 2.55%

% of portfolio

5.4%

Previous 5.53%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $121,125 - $205,314	-1,900 Reduced 0.48%	398,100 $27.9 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $2.14 Million - $6.64 Million	-79,538 Reduced 16.59%	400,000 $33.4 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $4.32 Million - $5.37 Million	146,804 Added 44.12%	479,538 $14.1 Million
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $1.83 Million - $2.29 Million	56,239 Added 20.34%	332,734 $10.9 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $3.09 Million - $4.23 Million	92,500 Added 50.27%	276,495 $9.73 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $1.06 Million - $1.5 Million	-27,500 Reduced 13.0%	183,995 $8.92 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $2.3 Million - $3.56 Million	77,401 Added 57.72%	211,495 $7.79 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $1.41 Million - $1.9 Million	-40,906 Reduced 23.37%	134,094 $6.11 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $3.24 Million - $6.25 Million	175,000 New	175,000 $6.26 Million
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $3.66 Million - $6.83 Million	-418,727 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$10.82 - $14.25 $632,634 - $833,183	-58,469 Reduced 12.25%	418,727 $4.77 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $611,370 - $865,147	76,902 Added 19.21%	477,196 $5.37 Million
Q1 2019 May 15, 2019	BUY	$5.95 - $10.19 $1.28 Million - $2.19 Million	214,468 Added 115.41%	400,294 $3.24 Million
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $727,733 - $1.14 Million	123,136 Added 196.42%	185,826 $1.17 Million
Q3 2018 Nov 14, 2018	SELL	$6.4 - $9.85 $43,180 - $66,457	-6,747 Reduced 9.72%	62,690 $617,000
Q2 2018 Aug 13, 2018	BUY	$6.9 - $9.9 $479,115 - $687,426	69,437 New	69,437 $576,000

Others Institutions Holding CYTK

# of Institutions

407

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Cytokinetics Inc Transaction History